Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 16;14(6):e012459. doi: 10.1161/CIRCIMAGING.121.012459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors.

Circulation: Cardiovascular Imaging is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.

PMC Copyright notice

Figure 3. — Evaluation of the baseline values of normal myocardium (%) and left ventricular ejection fraction and prediction of cardiotoxicity (CTX) and recovery (REC). A, Differences between baseline values of (A) normal myocardium (%) and (B) left ventricular ejection fraction (LVEF) in patients with versus without CTX. C, Receiver operating characteristic (ROC) analysis for CTX prediction based on baseline cardiovascular magnetic resonance (CMR) values. D, ROC analysis for the prediction of REC in patients who had CTX and received cardioprotective treatment with β-blockers, ACE (angiotensin-converting enzyme)/angiotensin II receptor blockers or combination of both (Note that pooled data were used for this analysis, derived from CMR examinations just before the initiation of the cardioprotective therapies). AUC indicates areas under the curve.